Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Effectiveness of Influenza Vaccination Among Older Adults Across Kidney Function: Pooled Analysis of 2005-2006 Through 2014-2015 Influenza Seasons.

Ishigami J, Sang Y, Grams ME, Coresh J, Chang A, Matsushita K.

Am J Kidney Dis. 2019 Dec 6. pii: S0272-6386(19)31064-9. doi: 10.1053/j.ajkd.2019.09.008. [Epub ahead of print]

PMID:
31813664
2.

GSTM1 Deletion Exaggerates Kidney Injury in Experimental Mouse Models and Confers the Protective Effect of Cruciferous Vegetables in Mice and Humans.

Gigliotti JC, Tin A, Pourafshar S, Cechova S, Wang YT, Sung SJ, Bodonyi-Kovacs G, Cross JV, Yang G, Nguyen N, Chan F, Rebholz C, Yu B, Grove ML, Grams ME, Köttgen A, Scharpf R, Ruiz P, Boerwinkle E, Coresh J, Le TH.

J Am Soc Nephrol. 2019 Nov 14. pii: ASN.2019050449. doi: 10.1681/ASN.2019050449. [Epub ahead of print]

PMID:
31727850
3.

Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Clase CM, Carrero JJ, Ellison DH, Grams ME, Hemmelgarn BR, Jardine MJ, Kovesdy CP, Kline GA, Lindner G, Obrador GT, Palmer BF, Cheung M, Wheeler DC, Winkelmayer WC, Pecoits-Filho R; Conference Participants.

Kidney Int. 2019 Oct 10. pii: S0085-2538(19)31012-9. doi: 10.1016/j.kint.2019.09.018. [Epub ahead of print]

4.

Development of Risk Prediction Equations for Incident Chronic Kidney Disease.

Nelson RG, Grams ME, Ballew SH, Sang Y, Azizi F, Chadban SJ, Chaker L, Dunning SC, Fox C, Hirakawa Y, Iseki K, Ix J, Jafar TH, Köttgen A, Naimark DMJ, Ohkubo T, Prescott GJ, Rebholz CM, Sabanayagam C, Sairenchi T, Schöttker B, Shibagaki Y, Tonelli M, Zhang L, Gansevoort RT, Matsushita K, Woodward M, Coresh J, Shalev V; CKD Prognosis Consortium.

JAMA. 2019 Nov 8. doi: 10.1001/jama.2019.17379. [Epub ahead of print]

PMID:
31703124
5.

Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer Assay.

Tin A, Yu B, Ma J, Masushita K, Daya N, Hoogeveen RC, Ballantyne CM, Couper D, Rebholz CM, Grams ME, Alonso A, Mosley T, Heiss G, Ganz P, Selvin E, Boerwinkle E, Coresh J.

J Appl Lab Med. 2019 Jul;4(1):30-39. doi: 10.1373/jalm.2018.027086. Epub 2019 Jan 22.

6.

Trends in Self-reported Prediabetes and Metformin Use in the USA: NHANES 2005-2014.

Liu C, Foti K, Grams ME, Shin JI, Selvin E.

J Gen Intern Med. 2019 Oct 21. doi: 10.1007/s11606-019-05398-5. [Epub ahead of print]

PMID:
31637644
7.

Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease.

Qiao Y, Shin JI, Sang Y, Inker LA, Secora A, Luo S, Coresh J, Alexander GC, Jackson JW, Chang AR, Grams ME.

Mayo Clin Proc. 2019 Nov;94(11):2220-2229. doi: 10.1016/j.mayocp.2019.05.031. Epub 2019 Oct 13.

PMID:
31619367
8.

Associations of Opioid Prescriptions with Death and Hospitalization across the Spectrum of Estimated GFR.

Novick TK, Surapaneni A, Shin JI, Alexander GC, Inker LA, Wright EA, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1581-1589. doi: 10.2215/CJN.00440119. Epub 2019 Oct 3.

PMID:
31582462
9.

Chronic Kidney Disease Diagnosis and Management: A Review.

Chen TK, Knicely DH, Grams ME.

JAMA. 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745. Review.

PMID:
31573641
10.

Lifetime Risk of Lower-Extremity Peripheral Artery Disease Defined by Ankle-Brachial Index in the United States.

Matsushita K, Sang Y, Ning H, Ballew SH, Chow EK, Grams ME, Selvin E, Allison M, Criqui M, Coresh J, Lloyd-Jones DM, Wilkins JT.

J Am Heart Assoc. 2019 Sep 17;8(18):e012177. doi: 10.1161/JAHA.119.012177. Epub 2019 Sep 10.

11.

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.

Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, Greene T, Tighiouart H, Matsushita K, Ballew SH, Sang Y, Vonesh E, Ying J, Manley T, de Zeeuw D, Eckardt KU, Levin A, Perkovic V, Zhang L, Willis K.

Am J Kidney Dis. 2019 Aug 23. pii: S0272-6386(19)30883-2. doi: 10.1053/j.ajkd.2019.06.009. [Epub ahead of print]

PMID:
31473020
12.

Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.

Matsushita K, Sang Y, Yang C, Ballew SH, Grams ME, Coresh J, Molnar MZ.

PLoS One. 2019 Aug 8;14(8):e0219899. doi: 10.1371/journal.pone.0219899. eCollection 2019.

13.

Dietary patterns and risk of incident chronic kidney disease: the Atherosclerosis Risk in Communities study.

Hu EA, Steffen LM, Grams ME, Crews DC, Coresh J, Appel LJ, Rebholz CM.

Am J Clin Nutr. 2019 Sep 1;110(3):713-721. doi: 10.1093/ajcn/nqz146.

PMID:
31386145
14.

APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.

Grams ME, Surapaneni A, Ballew SH, Appel LJ, Boerwinkle E, Boulware LE, Chen TK, Coresh J, Cushman M, Divers J, Gutiérrez OM, Irvin MR, Ix JH, Kopp JB, Kuller LH, Langefeld CD, Lipkowitz MS, Mukamal KJ, Musani SK, Naik RP, Pajewski NM, Peralta CA, Tin A, Wassel CL, Wilson JG, Winkler CA, Young BA, Zakai NA, Freedman BI.

J Am Soc Nephrol. 2019 Oct;30(10):2027-2036. doi: 10.1681/ASN.2019030240. Epub 2019 Aug 5.

PMID:
31383730
15.

Sickle cell trait, estimated glomerular filtration rate, and risk of adverse outcomes in chronic kidney disease.

Sood R, Surapaneni A, Luo S, Appel LJ, Winkler C, Grams ME, Naik RP.

Am J Hematol. 2019 Oct;94(10):E275-E278. doi: 10.1002/ajh.25588. Epub 2019 Aug 9. No abstract available.

PMID:
31342549
16.

Hospitalization Risk among Older Adults with Chronic Kidney Disease.

Wong E, Ballew SH, Daya N, Ishigami J, Rebholz CM, Matsushita K, Grams ME, Coresh J.

Am J Nephrol. 2019;50(3):212-220. doi: 10.1159/000501539. Epub 2019 Jul 16.

PMID:
31311014
17.

Proteinuria and Risk of Lower-Extremity Amputation in Patients With Peripheral Artery Disease.

Shin JI, Grams ME, Coresh J, Chang AR, Matsushita K.

Diabetes Care. 2019 Sep;42(9):e146-e147. doi: 10.2337/dc19-0764. Epub 2019 Jul 15. No abstract available.

PMID:
31308019
18.

Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data.

Grams ME, Sang Y, Ballew SH, Matsushita K, Astor BC, Carrero JJ, Chang AR, Inker LA, Kenealy T, Kovesdy CP, Lee BJ, Levin A, Naimark D, Pena MJ, Schold JD, Shalev V, Wetzels JFM, Woodward M, Gansevoort RT, Levey AS, Coresh J.

J Am Soc Nephrol. 2019 Sep;30(9):1746-1755. doi: 10.1681/ASN.2019010008. Epub 2019 Jul 10.

PMID:
31292199
19.

Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study.

Yu Z, Rebholz CM, Wong E, Chen Y, Matsushita K, Coresh J, Grams ME.

Am J Kidney Dis. 2019 Sep;74(3):310-319. doi: 10.1053/j.ajkd.2019.02.015. Epub 2019 Apr 25.

PMID:
31031087
20.

Safely treating pain in older adults.

Novick TK, Grams ME.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1075-1077. doi: 10.1093/ndt/gfz071. No abstract available.

PMID:
31028404
21.

Plant-Based Diets and Incident CKD and Kidney Function.

Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Grams ME, Coresh J, Rebholz CM.

Clin J Am Soc Nephrol. 2019 May 7;14(5):682-691. doi: 10.2215/CJN.12391018. Epub 2019 Apr 25.

PMID:
31023928
22.

Serum Metabolites and Cardiac Death in Patients on Hemodialysis.

Hu JR, Grams ME, Coresh J, Hwang S, Kovesdy CP, Guallar E, Rhee EP, Shafi T.

Clin J Am Soc Nephrol. 2019 May 7;14(5):747-749. doi: 10.2215/CJN.12691018. Epub 2019 Apr 8. No abstract available.

PMID:
30962187
23.

Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.

Mok Y, Ballew SH, Sang Y, Grams ME, Coresh J, Evans M, Barany P, Ärnlöv J, Carrero JJ, Matsushita K.

J Am Heart Assoc. 2019 Apr 16;8(8):e010546. doi: 10.1161/JAHA.118.010546.

24.

The Serum Metabolome Identifies Biomarkers of Dietary Acid Load in 2 Studies of Adults with Chronic Kidney Disease.

Rebholz CM, Surapaneni A, Levey AS, Sarnak MJ, Inker LA, Appel LJ, Coresh J, Grams ME.

J Nutr. 2019 Apr 1;149(4):578-585. doi: 10.1093/jn/nxy311.

PMID:
30919901
25.

Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States.

Ishigami J, Padula WV, Grams ME, Chang AR, Jaar B, Gansevoort RT, Bridges JFP, Kovesdy CP, Uchida S, Coresh J, Matsushita K.

Am J Kidney Dis. 2019 Jul;74(1):23-35. doi: 10.1053/j.ajkd.2019.01.025. Epub 2019 Mar 19.

PMID:
30898360
26.

Alcohol Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities Study.

Hu EA, Lazo M, Rosenberg SD, Grams ME, Steffen LM, Coresh J, Rebholz CM.

J Ren Nutr. 2019 Mar 5. pii: S1051-2276(19)30029-9. doi: 10.1053/j.jrn.2019.01.011. [Epub ahead of print]

PMID:
30850190
27.

Inconsistencies in Reporting Studies of Lactic Acidosis-Reply.

Lazarus B, Grams ME.

JAMA Intern Med. 2019 Mar 1;179(3):456. doi: 10.1001/jamainternmed.2018.8594. No abstract available.

PMID:
30830196
28.

Integrative Omics for Identifying Dysfunctional Pathways in CKD.

Tin A, Grams ME.

Kidney Int Rep. 2018 Dec 18;4(2):194-195. doi: 10.1016/j.ekir.2018.12.009. eCollection 2019 Feb. No abstract available.

29.

Neighborhood Poverty and Sex Differences in Live Donor Kidney Transplant Outcomes in the United States.

Purnell TS, Luo X, Crews DC, Bae S, Ruck JM, Cooper LA, Grams ME, Henderson ML, Waldram MM, Johnson M, Segev DL.

Transplantation. 2019 Oct;103(10):2183-2189. doi: 10.1097/TP.0000000000002654.

PMID:
30768570
30.

Serum metabolites associated with dietary protein intake: results from the Modification of Diet in Renal Disease (MDRD) randomized clinical trial.

Rebholz CM, Zheng Z, Grams ME, Appel LJ, Sarnak MJ, Inker LA, Levey AS, Coresh J.

Am J Clin Nutr. 2019 Mar 1;109(3):517-525. doi: 10.1093/ajcn/nqy202.

PMID:
30753252
31.

Serum Metabolomic Alterations Associated with Proteinuria in CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Appel LJ, Chen J, Vasan RS, Anderson AH, Feldman HI, Kimmel PL, Waikar SS, Köttgen A, Evans AM, Levey AS, Inker LA, Sarnak MJ, Grams ME; Chronic Kidney Disease Biomarkers Consortium Investigators.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):342-353. doi: 10.2215/CJN.10010818. Epub 2019 Feb 7.

PMID:
30733224
32.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.

PMID:
30635225
33.

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.

Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M; CKD Prognosis Consortium (CKD-PC).

BMJ. 2019 Jan 10;364:k5301. doi: 10.1136/bmj.k5301.

34.

Elevated Vancomycin Trough Levels in a Tertiary Health System: Frequency, Risk Factors, and Prognosis.

Zonozi R, Wu A, Shin JI, Secora A, Coresh J, Inker LA, Chang AR, Grams ME.

Mayo Clin Proc. 2019 Jan;94(1):17-26. doi: 10.1016/j.mayocp.2018.08.034.

PMID:
30611444
35.

Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD.

Novick TK, Surapaneni A, Shin JI, Ballew SH, Alexander GC, Inker LA, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1886-1888. doi: 10.2215/CJN.08530718. Epub 2018 Nov 8. No abstract available.

36.

Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium.

Inker LA, Grams ME, Levey AS, Coresh J, Cirillo M, Collins JF, Gansevoort RT, Gutierrez OM, Hamano T, Heine GH, Ishikawa S, Jee SH, Kronenberg F, Landray MJ, Miura K, Nadkarni GN, Peralta CA, Rothenbacher D, Schaeffner E, Sedaghat S, Shlipak MG, Zhang L, van Zuilen AD, Hallan SI, Kovesdy CP, Woodward M, Levin A; CKD Prognosis Consortium.

Am J Kidney Dis. 2019 Feb;73(2):206-217. doi: 10.1053/j.ajkd.2018.08.013. Epub 2018 Oct 19.

PMID:
30348535
37.

Coffee consumption and liver-related hospitalizations and deaths in the ARIC study.

Hu EA, Lazo M, Selvin E, Hamilton JP, Grams ME, Steffen LM, Coresh J, Rebholz CM.

Eur J Clin Nutr. 2019 Aug;73(8):1133-1140. doi: 10.1038/s41430-018-0346-0. Epub 2018 Oct 19.

38.

Chronic kidney disease measures and the risk of abdominal aortic aneurysm.

Matsushita K, Kwak L, Ballew SH, Grams ME, Selvin E, Folsom AR, Coresh J, Tang W.

Atherosclerosis. 2018 Dec;279:107-113. doi: 10.1016/j.atherosclerosis.2018.08.043. Epub 2018 Sep 1.

39.

Lactic Acidosis, Metformin Use, and Dose-Response Association-Reply.

Lazarus B, Shin JI, Grams ME.

JAMA Intern Med. 2018 Oct 1;178(10):1427-1428. doi: 10.1001/jamainternmed.2018.4430. No abstract available.

PMID:
30285140
40.

Proton Pump Inhibitors in Kidney Disease.

Lazarus B, Grams ME.

Clin J Am Soc Nephrol. 2018 Oct 8;13(10):1458-1459. doi: 10.2215/CJN.10110818. Epub 2018 Sep 27. No abstract available.

41.

Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study.

Oelsner EC, Balte PP, Grams ME, Cassano PA, Jacobs DR, Barr RG, Burkart KM, Kalhan R, Kronmal R, Loehr LR, O'Connor GT, Schwartz JE, Shlipak M, Tracy RP, Tsai MY, White W, Yende S.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):321-332. doi: 10.1164/rccm.201803-0402OC.

PMID:
30261735
42.

Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME.

Drugs Aging. 2018 Aug;35(8):735-750. doi: 10.1007/s40266-018-0563-1.

43.

Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.

Shin JI, Secora A, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1144-1152. doi: 10.2215/CJN.13811217. Epub 2018 Jul 12.

44.

Prognostic Implications of Single-Sample Confirmatory Testing for Undiagnosed Diabetes: A Prospective Cohort Study.

Selvin E, Wang D, Matsushita K, Grams ME, Coresh J.

Ann Intern Med. 2018 Aug 7;169(3):156-164. doi: 10.7326/M18-0091. Epub 2018 Jun 19.

45.

Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD.

Luo S, Coresh J, Tin A, Rebholz CM, Chen TK, Hayek SS, Tracy M, Lipkowitz MS, Appel LJ, Levey AS, Inker LA, Reiser J, Grams ME.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1013-1021. doi: 10.2215/CJN.13631217. Epub 2018 Jun 14.

46.

Socioeconomic status and risk of kidney dysfunction: the Atherosclerosis Risk in Communities study.

Vart P, Grams ME, Ballew SH, Woodward M, Coresh J, Matsushita K.

Nephrol Dial Transplant. 2018 Jun 11. doi: 10.1093/ndt/gfy142. [Epub ahead of print]

PMID:
29897587
47.

Serum metabolites are associated with all-cause mortality in chronic kidney disease.

Hu JR, Coresh J, Inker LA, Levey AS, Zheng Z, Rebholz CM, Tin A, Appel LJ, Chen J, Sarnak MJ, Grams ME.

Kidney Int. 2018 Aug;94(2):381-389. doi: 10.1016/j.kint.2018.03.008. Epub 2018 Jun 2.

48.

Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.

Lazarus B, Wu A, Shin JI, Sang Y, Alexander GC, Secora A, Inker LA, Coresh J, Chang AR, Grams ME.

JAMA Intern Med. 2018 Jul 1;178(7):903-910. doi: 10.1001/jamainternmed.2018.0292.

49.

Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study.

Warren B, Rebholz CM, Sang Y, Lee AK, Coresh J, Selvin E, Grams ME.

Diabetes Care. 2018 Aug;41(8):1646-1653. doi: 10.2337/dc18-0277. Epub 2018 Jun 1.

50.

Risk Factors for Prognosis in Patients With Severely Decreased GFR.

Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC.

Kidney Int Rep. 2018 Jan 11;3(3):625-637. doi: 10.1016/j.ekir.2018.01.002. eCollection 2018 May. Erratum in: Kidney Int Rep. 2018 Aug 30;3(6):1506.

Supplemental Content

Loading ...
Support Center